x

Search for a clinical trial

* (*) mandatory field

60 Result(s)

Sort by

Recruiting trial = Recruiting trial
; Ongoing trial = Ongoing trial
; Funded by an IRDiRC member =

National clinical trial(s)

GERMANY

Baden-Württemberg
HEIDELBERG

SAHA-I: A Phase II Study to investigate the efficacy and tolerability of Vorinostat in patients suffering from advanced, metastatic Soft Tissue Sarcoma - DE
Zentrum für Innere Medizin (Krehl-Klinik)
Abteilung Innere Medizin V - Hämatologie, Onkologie und Rheumatologie

GERMANY

Niedersachsen
HANNOVER

IRELAND

County Dublin
DUBLIN

Recruiting trial
Ongoing trial
European Paediatric Soft Tissue Sarcoma Study Group protocol for Localized Non-Rhabdomyosarcoma Soft Tissue Sarcomas 2005 (phase III) - IE
Our Lady's Children's Hospital
National Oncology/ Bone Marrow Transplant Centre and Haematology Department

SPAIN

Cataluña
BARCELONA

Localized Non-Rhabdomyosarcoma Soft Tissue Sarcomas (Phase III) (terminated)
Hospital Universitari Vall d'Hebron - Area Materno Infantil
Servicio de Oncología y Hematología Pediátricas

UNITED KINGDOM

Greater Manchester
MANCHESTER

UNITED KINGDOM

South Yorkshire
SHEFFIELD

FRANCE

AUVERGNE-RHONE-ALPES
NOT YET IDENTIFIED - FR

FRANCE

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

GERMANY

Nordrhein-Westfalen
MÜNSTER

Doxo: Phase II pharmacokinetic study to assess the age-dependency in the clearance of Doxorubicin in paediatric patients with Solid Tumours and Leukaemia - DE - Completed
Universitätsklinikum Münster
Klinik für Kinder- und Jugendmedizin - Pädiatrische Hämatologie und Onkologie

UNITED KINGDOM

Tyne & Wear
NEWCASTLE UPON TYNE

Phase II pharmacokinetic study to assess the age-dependency in the clearance of Doxorubicin in paediatric patients with Solid Tumours and Leukaemia - UK
Northern Institute for Cancer Research, Medical School, Newcastle University
Northern Institute for Cancer Research

UNITED KINGDOM

Greater Manchester
NOT YET IDENTIFIED - UK

Multinational clinical trial(s)